Investigating the perceived timing of sensory events triggering actions in patients with Parkinson's disease and the effects of dopaminergic therapy.


Journal

Cortex; a journal devoted to the study of the nervous system and behavior
ISSN: 1973-8102
Titre abrégé: Cortex
Pays: Italy
ID NLM: 0100725

Informations de publication

Date de publication:
06 2019
Historique:
received: 25 07 2018
revised: 08 01 2019
accepted: 10 02 2019
pubmed: 23 3 2019
medline: 4 9 2020
entrez: 23 3 2019
Statut: ppublish

Résumé

Few studies have investigated if Parkinson's disease (PD), advancing age, or exogenous dopamine therapy affect the perceived timing of past events. Here we show a phenomenon of 'temporal repulsion' of a sensory event relative to an action decision in patients with PD. In these patients, the timing of a sensory event triggering an action was perceived to have occurred earlier in time than it really did. In other words, the event appeared to be pushed away in time from the performance of the action. This finding stands in sharp contrast to the 'temporal binding' we have observed here and elsewhere (Yabe et al., 2017; Yabe & Goodale, 2015) in young healthy participants for whom the perceived onset of a sensory event triggering an action is typically delayed, as if it were pulled towards the action in time. In elderly patients, sensory events were neither repulsed nor pulled toward the action decision event. Exogenous dopamine alleviated the temporal repulsion in PD patients and normalized the temporal binding in healthy elderly controls. In contrast, dopaminergic therapy worsened temporal binding in healthy young participants. We discuss this pattern of findings, relating temporal binding processes to dopaminergic and striatal mechanisms.

Identifiants

pubmed: 30901554
pii: S0010-9452(19)30061-9
doi: 10.1016/j.cortex.2019.02.009
pii:
doi:

Substances chimiques

Antiparkinson Agents 0
Levodopa 46627O600J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

309-323

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Yoshiko Yabe (Y)

NTT Communication Science Laboratories, Nippon Telegraph and Telephone Corporation, Atsugi, Kanagawa, Japan; The Brain and Mind Institute, The University of Western Ontario, Western Interdisciplinary Research Building, London, Ontario, Canada; Research Institute, Kochi University of Technology, Kami, Kochi, Japan; Japan Society for the Promotion of Science (JSPS), Kojimachi Business Center Bldg., Tokyo, Japan. Electronic address: yy47151@gmail.com.

Melvyn A Goodale (MA)

The Brain and Mind Institute, The University of Western Ontario, Western Interdisciplinary Research Building, London, Ontario, Canada.

Penny A MacDonald (PA)

The Brain and Mind Institute, The University of Western Ontario, Western Interdisciplinary Research Building, London, Ontario, Canada; Clinical Neurological Sciences, London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH